About Frank McCaney
Form D filings for Diasome Pharmaceuticals from 2017 to 2024 list Frank McCaney as director.
Frank McCaney first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Frank McCaney in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Frank McCaney works with at each company, as listed on that company's latest Form D.
Diasome Pharmaceuticals, Inc. · Form D, Aug 15, 2024
PT
Peter Tollman
Director
RG
Robert Geho
Chief Executive Officer and director
WG
W. Geho
Executive officer and director
TM
Thomas McDonald
Director
CO
Cosme Ordonez
Director